| 摘要 |
The invention relates to the F-crystal form, G-crystal form, H-crystal form, l-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide: (see formula I) certain processes for their preparation, pharmaceutical compositions containing these crystal forms, their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans. |
